PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
Condition:   Pancreatic Cancer Interventions:   Drug: Trametinib;   Drug: Hydroxychloroquine Sponsors:   Cancer Trials Ireland;   Novartis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2022 Category: Research Source Type: clinical trials